Amanda Cunningham
Nurse Practitioner · Smyrna, TNNPI 1902303514
Payments from drug & device makers
Across 132 payments — averaging $18.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$383
- AbbVie$338
- Pfizer$257
- AstraZeneca$214
- Esperion Therapeutics, Inc.$101
- Lilly USA, LLC$84
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,396100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 23 | $383 |
| AbbVie | 19 | $338 |
| Pfizer | 14 | $257 |
| AstraZeneca | 9 | $214 |
| Esperion Therapeutics, Inc. | 6 | $101 |
| Lilly USA, LLC | 5 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Bayer | 4 | $81 |
| Boehringer Ingelheim | 4 | $67 |
| Antares Pharma, Inc. | 3 | $55 |
| Inspire Medical Systems, Inc. | 2 | $54 |
| Sanofi-aventis U.S. LLC | 4 | $53 |
| VBI Vaccine (delaware) Inc. | 3 | $53 |
| GSK | 3 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| Amarin Pharma, Inc. | 2 | $39 |
| Dexcom, Inc. | 2 | $35 |
| Gilead | 2 | $35 |
| Amgen | 2 | $34 |
| CSL Behring | 1 | $31 |
| Astellas Pharma US Inc | 1 | $29 |
| Exact Sciences | 2 | $27 |
| Nevro Corp. | 1 | $26 |
| Cranial Technologies, Inc | 2 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Novartis | 1 | $22 |
| Grifols USA, LLC | 1 | $21 |
| Axonics, Inc. | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
| Merck | 1 | $13 |
| Eisai Inc. | 1 | $12 |
| Vistapharm, Inc. | 1 | $12 |
How this compares
$2,396 in reported general payments places this provider in the 80th percentile of 2,662 nurse practitioner providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 31 | $481 |
| Potassium Chloride | 19 | $442 |
| Cefdinir | 24 | $327 |
| Duloxetine Hcl | 17 | $324 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $228 |
| Gabapentin | 13 | $178 |
| Prednisone | 22 | $141 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $141 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $102 |
| Hydroxyzine Hcl | 11 | $91 |
| Amlodipine Besylate | 19 | $69 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $66 |
| Alendronate Sodium | 13 | $27 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Smyrna
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Erica HembreeKnoxville$125K
- Brooke FaughtNashville$89K
- Lauren WelchNashville$71K
- Cara StoutKingsport$71K
- S Marie HamiltonOoltewah$64K
- Cynthia WilsonChattanooga$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.